Kyaw Min Khant
Clinical Cardiac Electrophysiology · Richmond, VANPI 1992202907
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (58.3%), food and beverage and grants — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Boston Scientific at 25.1% of the total. 2025 is the largest year on record at $31,618, more than ten times the $13 reported in 2021.
Across 392 payments — averaging $131.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$13K
- Biotronik Inc.$9K
- Medtronic$9K
- Abbott$7K
- Biosense Webster, Inc.$6K
- Medical Device Business Services, Inc.$4K
- plus $2K from 17 others
What the payments were for
- Grants$1,7463%
- Travel & lodging$30,02558%
- Food & beverage$18,44836%
- Education$1,2652%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 63 | $12,908 |
| Biotronik Inc. | 65 | $9,365 |
| Medtronic | 81 | $9,142 |
| Abbott | 60 | $7,366 |
| Biosense Webster, Inc. | 50 | $6,003 |
| Medical Device Business Services, Inc. | 29 | $4,357 |
| Abiomed | 5 | $467 |
| Amgen | 11 | $332 |
| Atricure, Inc. | 3 | $244 |
| Irhythm Technologies, Inc. | 2 | $229 |
| Sanofi | 2 | $148 |
| Novo Nordisk | 2 | $136 |
| Shockwave Medical, Inc | 1 | $135 |
| Scpharmaceuticals Inc. | 1 | $125 |
| AstraZeneca | 1 | $125 |
| Novartis | 5 | $96 |
| Vital Connect, Inc | 1 | $95 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $77 |
| Terumo Medical Corporation | 2 | $43 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Cardiva Medical, Inc. | 1 | $24 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$7,282
- Farapulse$4,861
- GENERAL - THERAPIES$4,189
- GALLANT$3,028
- ENSITE$1,462
- WATCHMAN Access System$1,438
- Acticor 7 VR-T DX$1,426
- ENSITE PRECISION$794
- PAMIRA$700
- Rivacor 7 DR-T$673
- Edora 8 DR-T$655
- VersaCross Connect LAAC Access Solution$630
- Sentus$548
- BioMonitor$305
- AMVIA EDGE$283
- VersaCross Access Solution$238
- ADVISA DR MRI SURESCAN$178
- Zio monitor$176
- ZIO XT Patch$176
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$164
How this compares
$51,484 in reported general payments places this provider in the 75th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
See all clinical cardiac electrophysiology providers in Virginia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $72,494 |
| EntrestoSacubitril/Valsartan | 36 | $64,945 |
| FarxigaDapagliflozin Propanediol | 32 | $36,892 |
| JardianceEmpagliflozin | 11 | $18,565 |
| Repatha SureclickEvolocumab | 15 | $9,425 |
| Ranolazine ErRanolazine | 22 | $2,495 |
| Valsartan | 38 | $577 |
| Atorvastatin Calcium | 89 | $560 |
| Bumetanide | 32 | $512 |
| Metoprolol Succinate | 67 | $481 |
| Lisinopril | 78 | $478 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 46 | $453 |
| Furosemide | 68 | $345 |
| SotalolSotalol Hcl | 17 | $343 |
| Spironolactone | 54 | $329 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $13 | $72,49471 claims |
| NovartisEntresto | $96 | $64,94536 claims |
| AstraZenecaFarxiga | $125 | $36,89232 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
Other clinical cardiac electrophysiology in Richmond
- Kenneth EllenbogenRichmond$360K
- Ajay PillaiRichmond$129K
- Charles JoynerRichmond$85K
- Binaya BasyalRichmond$79K
- Jayanthi KoneruRichmond$62K
- Jacob BlackwellRichmond$49K
- Pranav MankadRichmond$30K
- Vybhav JettyRichmond$20K
- Harsimran SainiRichmond$17K
- David GilliganRichmond$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.